| Filed On | Filing |
|---|---|
| 07 Oct 2026 |
Form 4: Enguent Jean-Pierre, Vice President, R&DSS
Received 35,000 shares by exercise or conversion ($350) · Granted 50,000 Employee Stock Option Plan (right to buy) · Sold 35,000 shares ($85.9K) |
| 06 Oct 2026 |
Form 4: Fergusson David Alexander, Director
Granted 17,487 Employee Stock Option Plan (right to buy) |
| 06 Oct 2026 |
Form 4: Pellaton Eric Adrien, Director
Granted 24,810 Employee Stock Option Plan (right to buy) |
| 06 Oct 2026 |
Form 4: Ward Peter, Director
Granted 8,268 Employee Stock Option Plan (right to buy) |
| 03 Sep 2026 |
Form 4: Enguent Jean-Pierre, Vice President, R&DSS
Received 15,000 shares by exercise or conversion ($150) · Sold 15,000 shares ($36K) |
| 05 Aug 2026 |
Form 4: Enguent Jean-Pierre, Vice President, R&DSS
Received 15,000 shares by exercise or conversion ($150) · Sold 15,000 shares ($36.9K) |
| 08 Jul 2026 |
Form 4: Enguent Jean-Pierre, Vice President, R&DSS
Received 15,000 shares by exercise or conversion ($150) · Sold 15,000 shares ($42.3K) |
| 18 Jun 2026 |
Form 4: Ward Peter, Director
Received 366,746 shares by exercise or conversion ($3.67K) · Gave up 96,530 shares to cover exercise price or tax ($296K) |
| 05 Jun 2026 |
Form 4: Moreira Carlos, Director
Sold 300 shares ($1.05K) |
| 05 Jun 2026 |
Form 4: O'Hara John Charles, Director
Sold 143 shares ($502) |
| 03 Jun 2026 |
Form 4: O'Hara John Charles, Director
Sold 10,000 shares ($36.9K) · Sold 5,582 shares ($19.7K) |
| 03 Jun 2026 |
Form 4: Moreira Carlos, Director
Sold 10,000 shares ($36.9K) · Sold 7,005 shares ($24.7K) |
| 03 Jun 2026 |
Form 4: Enguent Jean-Pierre, Vice President, R&DSS
Received 15,000 shares by exercise or conversion ($150) · Granted 60,000 Employee Stock Option Plan (right to buy) · Sold 15,000 shares ($52.7K) |
| 29 May 2026 |
Form 4: Moreira Carlos, Director
Sold 4,139 shares ($14.5K) · Sold 10,000 shares ($35.1K) |
| 29 May 2026 |
Form 4: O'Hara John Charles, Director
Sold 4,689 shares ($16.4K) · Sold 10,000 shares ($35.1K) |
| 15 May 2026 |
Form 4: Buonanno Franck Jean, Vice-President, Global Sales
Sold 20,000 shares ($58K) |
| 11 May 2026 |
Form 4: Buonanno Franck Jean, Vice-President, Global Sales
Received 20,000 shares by exercise or conversion ($200) |
| 07 May 2026 |
Form 4: Enguent Jean-Pierre, Vice President, R&DSS
Sold 15,000 shares ($47K) |
| 04 May 2026 |
Form 4: Enguent Jean-Pierre, Vice President, R&DSS
Received 15,000 shares by exercise or conversion ($150) |
| 24 Apr 2026 |
Form 4: O'Hara John Charles, Director
Sold 10,000 shares ($30.6K) · Sold 10,000 shares ($28.8K) · Sold 5,250 shares ($15.3K) |
Loading...